Abstract:Alpha herpesvirus (α-HV) particles enter their hosts from mucosal surfaces and efficiently maintain fast transport in peripheral nervous system (PNS) axons to establish infections in the peripheral ganglia. The path from axons to distant neuronal nuclei is challenging to dissect due to the difficulty of monitoring early events in a dispersed neuron culture model. We have established well-controlled, reproducible, and reactivateable latent infections in compartmented rodent neurons by infecting physically isolated axons with a small number of viral particles. This system not only recapitulates the physiological infection route but also facilitates independent treatment of isolated cell bodies or axons. Consequently, this system enables study not only of the stimuli that promote reactivation but also the factors that regulate the initial switch from productive to latent infection. Adeno-associated virus (AAV)-mediated expression of herpes simplex-1 (HSV-1) VP16 alone in neuronal cell bodies enabled the escape from silencing of incoming pseudorabies virus (PRV) genomes. Furthermore, the expression of HSV VP16 alone reactivated a latent PRV infection in this system. Surprisingly, the expression of PRV VP16 protein supported neither PRV escape from silencing nor reactivation. We compared transcription transactivation activity of both VP16 proteins in primary neurons by RNA sequencing and found that these homolog viral proteins produce different gene expression profiles. AAV-transduced HSV VP16 specifically induced the expression of proto-oncogenes including c-Jun and Pim2. In addition, HSV VP16 induces phosphorylation of c-Jun in neurons, and when this activity is inhibited, escape of PRV silencing is dramatically reduced.IMPORTANCEDuring latency, alpha herpesvirus genomes are silenced yet retain the capacity to reactivate. Currently, host and viral protein interactions that determine the establishment of latency, induce escape from genome silencing or reactivation are not completely understood. By using a compartmented neuronal culture model of latency, we investigated the effect of the viral transcriptional activator, VP16 on pseudorabies virus (PRV) escape from genome silencing. This model recapitulates the physiological infection route and enables the study of the stimuli that regulate the initial switch from a latent to productive infection. We investigated the neuronal transcriptional activation profiles of two homolog VP16 proteins (encoded by HSV-1 or PRV) and found distinct gene activation signatures leading to diverse infection outcomes. This study contributes to understanding of how alpha herpesvirus proteins modulate neuronal gene expression leading to the initiation of a productive or a latent infection.

Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines

[Mechanisms of Herpes Simplex Virus Latency and Reactivation].

Advances in the immunoescape mechanisms exploited by alphaherpesviruses

Molecular Aspects of Varicella-Zoster Virus Latency

A review of HSV pathogenesis, vaccine development, and advanced applications

Mechanisms of HSV gene regulation during latency and reactivation

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses

Neuronal expression of herpes simplex virus-1 VP16 protein induces pseudorabies virus escape from silencing and reactivation

A review of latency in the Alloherpesviridae family

Status Quo of the Researches on HSV Vaccines

The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion

Immune Response to Herpes Simplex Virus Infection and Vaccine Development

Pathogenesis and virulence of herpes simplex virus

HSV trafficking and development of gene therapy vectors with applications in the nervous system

Herpesvirus transport to the nervous system and back again.

Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents

Molecular studies of Varicella zoster virus

Therapeutic vaccines for herpesviruses

An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application

The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors